Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 USD | -2.39% | -3.32% | -16.05% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 78.19M |
---|---|---|---|---|---|
Net income 2024 * | -124M | Net income 2025 * | -145M | EV / Sales 2024 * | - |
Net cash position 2024 * | 254M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.78
x | P/E ratio 2025 * |
-1
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.97% |
Latest transcript on Athira Pharma, Inc.
1 day | -2.39% | ||
1 week | -3.32% | ||
Current month | -25.55% | ||
1 month | -19.69% | ||
3 months | -32.45% | ||
6 months | +32.47% | ||
Current year | -16.05% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 23-05-17 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 21-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 22-01-26 |
John Fluke
BRD | Director/Board Member | 81 | 12-12-31 |
Joseph Edelman
BRD | Director/Board Member | 67 | 20-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +5.94% | - | |
0.00% | 147 M€ | +5.02% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 2.09 | -1.88% | 128,081 |
24-04-19 | 2.13 | +3.40% | 203,913 |
24-04-18 | 2.06 | -2.37% | 198,077 |
24-04-17 | 2.11 | 0.00% | 111,525 |
24-04-16 | 2.11 | +2.43% | 165,036 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.05% | 80.1M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- ATHA Stock